Get the Stockscreener App
19.90
2.59%
-0.53
After Hours:
19.95
0.05
+0.25%
Tandem Diabetes Care Inc stock is traded at $19.90, with a volume of 1.36M.
It is down -2.59% in the last 24 hours and down -1.49% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$20.43
Open:
$20.04
24h Volume:
1.36M
Relative Volume:
0.70
Market Cap:
$1.38B
Revenue:
$1.03B
Net Income/Loss:
$-94.55M
P/E Ratio:
-14.20
EPS:
-1.4012
Net Cash Flow:
$-3.64M
1W Performance:
-7.14%
1M Performance:
-1.49%
6M Performance:
-14.99%
1Y Performance:
+60.61%
1-Day Range:
$19.49
$20.36
1-Week Range:
$19.49
$22.30
52-Week Range:
$11.46
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
19.90 | 1.57B | 1.03B | -94.55M | -3.64M | -1.4012 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-19-26 | Upgrade | Truist | Hold → Buy |
| Mar-17-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-23-26 | Upgrade | Lake Street | Hold → Buy |
| Feb-20-26 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-27-26 | Resumed | TD Cowen | Buy |
| Dec-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-25 | Resumed | Stifel | Hold |
| Sep-08-25 | Initiated | Oppenheimer | Outperform |
| Aug-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Aug-07-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-09-25 | Downgrade | Citigroup | Neutral → Sell |
| Jun-16-25 | Initiated | Truist | Hold |
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-08-24 | Initiated | Canaccord Genuity | Buy |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Mar-26-24 | Upgrade | Stifel | Hold → Buy |
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - Stocktwits
(TNDM) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
A Look at Tandem Diabetes Care Inc (TNDM) After 3.4% Decline -- GF Value $24.05 vs Price $20.56 - GuruFocus
Tandem Diabetes Care stock gains after recent rally in diabetes tech - AD HOC NEWS
TANDEM DIABETES CARE INC (TNDM) Stock Chart - ChartMill
3 Reasons TNDM is Risky and 1 Stock to Buy Instead - Yahoo Finance
TNDM Initiated Coverage On by William Blair -- Rating Set to Out - GuruFocus
Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics - Benzinga
William Blair initiates Tandem Diabetes stock with outperform rating By Investing.com - Investing.com Nigeria
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript - AOL.com
How Tandem’s Q2 Loss and Pharmacy Pivot Will Impact Tandem Diabetes Care (TNDM) Investors - simplywall.st
Tandem (TNDM) Earnings Brief: Profit Per Share Clears Its Benchmark in the Current Update; Price Action: Shares Finish 6.63% Up at the CloseEarnings Season Preview - Vinanet
Tandem Diabetes Care CFO Leigh Vosseller Reports RSU Vesting Transactions on August 15, 2026 - Kalkine Media
Tandem Diabetes Care CEO John F. Sheridan Reports August 2026 RSU Vesting and Tax Withholding Details - Kalkine Media
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Sheridan John F - Moomoo
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Morrison Susan - Moomoo
Tandem Diabetes (TNDM) CFO vests RSUs as shares withheld for tax - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) exec nets 475 shares after RSU vesting - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CEO vests 15,916 RSUs as shares withheld for tax - Stock Titan
Tandem Diabetes Care | 4: Statement of changes in beneficial ownership of securities-Officer Kyrillos Jean-Claude - Moomoo
Tandem Diabetes (NASDAQ: TNDM) CSO vests 3,014 RSUs, 1,618 withheld - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CLO RSUs vest, with shares withheld for taxes - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) CTO withholds 1,277 shares to cover RSU taxes - Stock Titan
Tandem Diabetes (NASDAQ: TNDM) holder to sell 131 RSU shares - Stock Titan
Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) (Q2 2026) Earnings Call Highligh - GuruFocus
Tandem Diabetes Care Inc (TNDM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Renaissance Technologies LLC Purchases New Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Cross Above 200-Day Moving AverageTime to Sell? - marketbeat.com
5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call - Yahoo Finance
TNDM|Tandem Diabetes Care Inc|Price:22.617|Chg%:-0.513 - TradingKey
(TNDM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up - The Globe and Mail
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Analyzing 25% Potential Upside with No Sell Ratings - DirectorsTalk Interviews
Tandem Diabetes Care Inc (TNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Tandem Diabetes (TNDM) Stock Is Trading Up Today - Yahoo Finance
TNDM Q2 Deep Dive: Pharmacy Channel Gains and Pipeline Execution Amid Margin Recovery - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance UK
Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Record Q2 Sales And PayGo Momentum - finance.yahoo.com
Tandem Diabetes Care (TNDM) Could Be 23% Below Fair Value After Q2 Results - Yahoo Finance
TNDM Maintained by Citigroup -- Price Target Raised to $21.00 - GuruFocus
Tandem Diabetes Care (NASDAQ:TNDM) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Deutsche Bank Adjusts Tandem Diabetes Care PT to $18 From $15.50, Maintains Hold Rating - Moomoo
Oppenheimer reiterates Tandem Diabetes stock rating on pharmacy gains By Investing.com - Investing.com South Africa
TNDM Maintained by RBC Capital -- Price Target Lowered to $26 - GuruFocus
Tandem Diabetes Care Is Maintained at Outperform by RBC Capital - Moomoo
Tandem Diabetes Care, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:TNDM) 2026-08-07 - Seeking Alpha
Tandem Diabetes Care's Underlying Q2 Trends Better Than Headline Suggests, RBC Says - marketscreener.com
Tandem Diabetes Care Q2 Earnings Call Highlights - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap DownWhat's Next? - MarketBeat
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tandem Diabetes Care Inc Stock (TNDM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sheridan John F | PRESIDENT & CEO |
Aug 15 '26 |
Option Exercise |
0.00 |
15,916 |
0 |
165,315 |
| Morrison Susan | EVP & Chief Admin. Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
2,827 |
0 |
53,283 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
1,010 |
0 |
30,825 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
3,014 |
0 |
2,425 |
| Carpenter Rick | EVP & Chief Technology Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
2,507 |
0 |
32,968 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
3,014 |
0 |
32,626 |
0.86%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):